HIP
RXRX icon

HUB Investment Partners’s Recursion Pharmaceuticals RXRX Stock Holding History

HUB Investment Partners’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.4K Buy
18,690
+3,169
+20% +$12.2K ﹤0.01% 1098
2025
Q4 		$63.5K Buy
+15,521
New +$76.9K ﹤0.01% 922
2025
Q3 		– Sell
-17,065
Closed -$86.3K – 921
2025
Q2 		$86.3K Buy
+17,065
New +$83.8K ﹤0.01% 687

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HUB Investment Partners's RXRX Position: Q1 2026 in Review

HUB Investment Partners increased its Recursion Pharmaceuticals (RXRX) stake by 20% in Q1 2026, buying an estimated $12.2K and bringing the position to 18,690 shares worth $57.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1098.

HUB Investment Partners first reported a position in RXRX in Q2 2025 and has held it in 3 quarters since. The position peaked at $86.3K in Q2 2025. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • HUB Investment Partners held 18,690 shares of Recursion Pharmaceuticals worth $57.4K as of Q1 2026.
  • HUB Investment Partners bought 3,169 Recursion Pharmaceuticals shares in Q1 2026, an estimated $12.2K.
  • Recursion Pharmaceuticals made up ﹤0.01% of HUB Investment Partners's portfolio in Q1 2026, its #1098 holding.
  • HUB Investment Partners first reported a position in Recursion Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • HUB Investment Partners's Recursion Pharmaceuticals position peaked at $86.3K in Q2 2025.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on HUB Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.